Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.40 |
| ▸ | TLR8 | Q9NR97 | 3/20 | 0.38 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MPO | P05164 | 2/20 | 0.36 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL438493 | 0.94 | KDM4E (0.46) | KDM4EALDH1A1PKMSLC9A1TLR8 | |
| SCHEMBL15189572 | 0.92 | KDM4E (0.44) | KDM4EALDH1A1PKMSLC9A1TLR8 | |
| SCHEMBL2340816 | 0.88 | — | — | |
| Butyric Acid SCHEMBL28289188 | 0.86 | MAPK1 (0.49) | KDM4EALDH1A1 | |
| SCHEMBL6755827 | 0.83 | KDM4E (0.57) | KDM4EALDH1A1PKMPOLBKMT2A | |
| SCHEMBL9442047 | 0.80 | KDM4E (0.47) | KDM4EALDH1A1PKMCYP1A2POLB | |
| SCHEMBL27986966 | 0.80 | KDM4E (0.47) | KDM4EALDH1A1PKMPOLBKMT2A | |
| SCHEMBL21960824 | 0.79 | KDM4E (0.43) | KDM4EALDH1A1PKMCYP1A2CYP2D6 | |
| Quinoline SCHEMBL27458348 | 0.78 | ALDH1A1 (0.45) | ALDH1A1SLC9A1TLR8CYP1A2CYP2C9 | |
| SCHEMBL13212232 | 0.78 | SLC9A1 (0.41) | KDM4EALDH1A1SLC9A1NR1H3CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512604-B1 | STABLE YELLOW IMIDAZOLIUM COMPOUNDS AND METHODS FOR THEIR USE | WELLA OPERATIONS US LLC (US) | 2023-05-31 | — | — | EP | disclosed |
| EP-3512604-B1 | STABLE YELLOW IMIDAZOLIUM COMPOUNDS AND METHODS FOR THEIR USE | WELLA OPERATIONS US LLC (US) | 2023-05-31 | — | — | EP | disclosed |
| EP-3512604-A1 | STABLE YELLOW IMIDAZOLIUM COMPOUNDS AND METHODS FOR THEIR USE | Noxell Corporation (US) | 2019-07-24 | — | — | EP | disclosed |
| US-10093807-B2 | Stable yellow imidazolium compounds | NOXELL CORPORATION (US) | 2018-10-09 | — | — | US | disclosed |
| US-20180078477-A1 | Method of Coloring Hair with Washfast Yellow Imidazolium Direct Dye Compounds | WELLA OPERATIONS US, LLC | 2018-03-22 | — | — | US | disclosed |
| US-20180078477-A1 | Method of Coloring Hair with Washfast Yellow Imidazolium Direct Dye Compounds | WELLA OPERATIONS US, LLC | 2018-03-22 | — | — | US | disclosed |
| US-20180078477-A1 | Method of Coloring Hair with Washfast Yellow Imidazolium Direct Dye Compounds | WELLA OPERATIONS US, LLC | 2018-03-22 | — | — | US | disclosed |
| US-20180079907-A1 | Stable Yellow Imidazolium Compounds | WELLA OPERATIONS US, LLC | 2018-03-22 | — | — | US | disclosed |
| US-20180079907-A1 | Stable Yellow Imidazolium Compounds | WELLA OPERATIONS US, LLC | 2018-03-22 | — | — | US | disclosed |
| US-20180079907-A1 | Stable Yellow Imidazolium Compounds | WELLA OPERATIONS US, LLC | 2018-03-22 | — | — | US | disclosed |
| CN-101006087-A | Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors | PFIZER (US) | 2007-07-25 | — | — | CN | disclosed |
| CN-1993359-A | Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors | AVENTIS PHARMA SA (FR) | 2007-07-04 | — | — | CN | disclosed |
| CN-1229099-C | Use of reactive dyes for dyeing hair | BASF AG (DE) | 2005-11-30 | — | — | CN | disclosed |
| CN-1264284-A | Application of reactive dye in hair dyeing | BASF AG (DE) | 2000-08-23 | — | — | CN | disclosed |
| US-4645838-A | Pyrazolopyridine compounds, and intermediates, useful as anxiolytic agents | ICI AMERICAS INC. (US) | 1987-02-24 | — | — | US | disclosed |
| EP-0094175-B1 | PYRAZOLOPYRIDINE COMPOUNDS | ICI AMERICAS INC. (US) | 1986-10-29 | — | — | EP | disclosed |
| US-4563525-A | Process for preparing pyrazolopyridine compounds | ICI AMERICAS INC. (US) | 1986-01-07 | — | — | US | disclosed |
| US-4511568-A | CNS-Depressant pyrazolopyridines | ICI AMERICAS INC. (US) | 1985-04-16 | — | — | US | disclosed |
| EP-0094175-A1 | Pyrazolopyridine compounds | ICI AMERICAS INC. (US) | 1983-11-16 | — | — | EP | disclosed |
| US-4375467-A | 5-(Pyridinyl)-1H-pyrazolo[3,4-b] pyridines and their cardiotonic use | STERLING DRUG INC. (US) | 1983-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180078477-A1 | Method of Coloring Hair with Washfast Yellow Imidazolium Direct Dye Compounds | WASHC4, TYR, WASHC5 | KDM4E 637/4885ALDH1A1 228/4885PKM 4262/4885 |
| US-10093807-B2 | Stable yellow imidazolium compounds | IK, NDUFV1, NDUFV2 | KDM4E 2746/4885ALDH1A1 1345/4885PKM 1040/4885 |
| US-20180079907-A1 | Stable Yellow Imidazolium Compounds | IK, NDUFV1, NDUFV2 | KDM4E 2746/4885ALDH1A1 1345/4885PKM 1040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.